These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 10030830

  • 1. Cilostazol inhibits the expression of activation-dependent membrane surface glycoprotein on the surface of platelets stimulated in vitro.
    Inoue T, Sohma R, Morooka S.
    Thromb Res; 1999 Feb 01; 93(3):137-43. PubMed ID: 10030830
    [Abstract] [Full Text] [Related]

  • 2. Cilostazol inhibits platelet-leukocyte interaction by suppression of platelet activation.
    Ito H, Miyakoda G, Mori T.
    Platelets; 2004 Aug 01; 15(5):293-301. PubMed ID: 15370100
    [Abstract] [Full Text] [Related]

  • 3. Paradoxical inhibition of fibrinogen binding and potentiation of alpha-granule release by specific types of inhibitors of glycoprotein IIb-IIIa.
    Schneider DJ, Taatjes DJ, Sobel BE.
    Cardiovasc Res; 2000 Jan 14; 45(2):437-46. PubMed ID: 10728364
    [Abstract] [Full Text] [Related]

  • 4. [Inhibition of L-arginine and cilostazol on activation of platelets in vitro].
    Zhou J, Liu JH, Xing YC, Wang DM, Ouyang XL.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct 14; 15(5):1079-83. PubMed ID: 17956695
    [Abstract] [Full Text] [Related]

  • 5. Loading solution prevents activation damage of human platelets before lyophilization.
    Zhou J, Zhang C, Liu J, Fan L, Yang L.
    Cryobiology; 2011 Dec 14; 63(3):229-34. PubMed ID: 21945819
    [Abstract] [Full Text] [Related]

  • 6. Aspirin inhibits surface glycoprotein IIb/IIIa, P-selectin, CD63, and CD107a receptor expression on human platelets.
    McKenzie ME, Malinin AI, Bell CR, Dzhanashvili A, Horowitz ED, Oshrine BR, Atar D, Serebruany VL.
    Blood Coagul Fibrinolysis; 2003 Apr 14; 14(3):249-53. PubMed ID: 12695747
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Activation in stored platelet concentrates: correlation between membrane expression of P-selectin, glycoprotein IIb/IIIa, and beta-thromboglobulin release.
    Rinder HM, Snyder EL, Bonan JL, Napychank PA, Malkus H, Smith BR.
    Transfusion; 1993 Jan 14; 33(1):25-9. PubMed ID: 7678708
    [Abstract] [Full Text] [Related]

  • 9. Comparative study of antiplatelet drugs in vitro: distinct effects of cAMP-elevating drugs and GPIIb/IIIa antagonists on thrombin-induced platelet responses.
    Matsumoto Y, Marukawa K, Okumura H, Adachi T, Tani T, Kimura Y.
    Thromb Res; 1999 Jul 01; 95(1):19-29. PubMed ID: 10403683
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Platelet activation studies with anti-CD41/61 monoclonal antibodies.
    Mateo A, Perez de la Lastra JM, Garrido JJ, Llanes D.
    Vet Immunol Immunopathol; 1996 Aug 01; 52(4):357-62. PubMed ID: 8896225
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential in vitro effects of the platelet glycoprotein IIb/IIIa inhibitors abixicimab or SR121566A on platelet aggregation, fibrinogen binding and platelet secretory parameters.
    Klinkhardt U, Kirchmaier CM, Westrup D, Breddin HK, Mahnel R, Graff J, Hild M, Harder S.
    Thromb Res; 2000 Feb 15; 97(4):201-7. PubMed ID: 10674406
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.